At Rocky Mountain MS Research Group our mission is to provide our patients with access to the very latest in MS research. We collaborate with larger national and international research efforts comprised of clinical researchers from academia and the pharmaceutical industry to evaluate new disease modifying therapies, explore biological markers that may be useful in predicting disease progression, and further improve the safety and efficacy of existing treatments. We strive to make a difference in the world of MS care while valuing the safety of our patients and upholding the highest standard of clinical research integrity.
Current Clinical Research Trials
At Rocky Mountain MS Research Group, we have several studies currently enrolling for patients with MS. However, federal guidelines mandate that all information presented to potential participants in a study has to be approved by an Independent Review Board (IRB) prior to sharing. Due to this regulation some information about clinical trials may not be posted on our website. All trials are posted on https://clinicaltrials.gov/. Studies are both investigator-initiated and pharmaceutical-sponsored trials.
If you are have questions about or are interested in participating in one of our clinical trials please contact our study team at 801-408-4584.
Participate in a study evaluating a potential treatment option for RRMS relapses
The OPTIONS Study is looking at how well a study drug works for adults with relapsing-remitting multiple sclerosis (RRMS) who are currently experiencing a relapse and have not benefited from high-dose corticosteroid treatment.
You might be able to take part in the OPTIONS Study if you:
- are at least 18 years of age
- have a diagnosis of RRMS
- are currently experiencing a relapse
- start treatment for the relapse within 14 days of the first signs of the relapse.
If you are interested in receiving more information about the study, please contact the study team at 801-408-4584 or Cassandra Fenton, email@example.com. You can also find a description of this study by visiting www.clinicaltrials.gov and searching for MNK14274069 or NCT03126760.
FAQs Regarding Clinical Trial Participation
What are clinical studies?
Clinical studies are research studies in which real people participate as volunteers. Clinical research studies (sometimes called trials) are a means of developing new treatments and medications for diseases and conditions. There are strict rules for clinical trials, which are monitored by the National Institutes of Health and the U.S. Food and Drug Administration. Some of the research studies at the Clinical Center involve promising new treatments that may directly benefit patients.
Why should I participate?
The health of millions has been improved because of advances in science and technology, and the willingness of thousands of individuals like you to take part in clinical research. The role of volunteer subjects as partners in clinical research is crucial in the quest for knowledge that will improve the health of future generations. Without your help, the research studies at the Clinical Center cannot be accomplished.
Do I need to be a patient of Rocky Mountain MS Clinic to participate in clinical trials?
To participate at Rocky Mountain MS Clinic you do not necessarily need to be a patient of one of the physicians or providers at the clinic. It is completely acceptable to keep your current physician and still participate in Rocky Mountain MS Research Group’s clinical trials. Make sure you speak with your regular physician to see if participation is a good path for you.
Are there risks involved in participating in clinical research?
Risks are involved in clinical research, as in routine medical care and activities of daily living. In thinking about the risks of research, it is helpful to focus on two things: the degree of harm that could result from taking part in the study, and the chance of any harm occurring. Most clinical studies pose risks of minor discomfort, lasting only a short time. Some volunteer subjects, however, experience complications that require medical attention. The specific risks associated with any research protocol are described in detail in the consent document, which you are asked to sign before taking part in research. In addition, the major risks of participating in a study will be explained to you by a member of the research team, who will answer your questions about the study. Before deciding to participate, you should carefully weigh these risks. Although you may not receive any direct benefit as a result of participating in research, the knowledge developed may help others.
Will I be compensated?
Depending on the specific study, study participants may be compensated for their time and, in some instances, for the inconvenience of a procedure. Every clinical site reports compensation of $600 or more to the Internal Revenue Service and sends a “Form 1099-Other Income” to the participant at the end of the year. Please be aware that some or all of that compensation may be garnished if the participant has outstanding debts to the federal government.
How do I request information about active trials?
If you are have questions about or are interested in participating in one of our clinical trials please contact our study team at 801-408-4584. We will discuss with you the ongoing trials available and what criteria must be met in order to participate.